Company: CUB
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001213900-25-109274
Chunk: 72

Company: Lionheart Holdings
Filing Date: 2025-11-12
Form: 10-Q
Item: Part I, Item 8
Chunk 72
---
 $0.22  
    $0.19  
    $0.19 

Concentration of Credit Risk

Financial instruments that
potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution and the cash held
in the Trust Account, which, at times may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred
or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations,
and cash flows.

Warrant Instruments

The Company accounts for
the Warrants issued in connection with the Initial Public Offering and the Private Placement in accordance with the guidance contained
in FASB ASC Topic 815, “Derivatives and Hedging”. Accordingly, the Company evaluated and classified the warrant instruments
under equity treatment at their assigned values.

Recent Accounting Pronouncements

In November 2023, the FASB
issued ASU Topic 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (“ASU 2023-07”).
The amendments in ASU 2023-07 require disclosures, on an annual and interim basis, of significant segment expenses that are regularly
provided to the chief operating decision maker (“CODM”), as well as the aggregate amount of other segment items included in
the reported measure of segment profit or loss. ASU 2023-07 requires that a public entity disclose the title and position of the CODM
and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding
how to allocate resources. Public entities will be required to provide all annual disclosures currently required by FASB ASC Topic 280, ”Segment
Reporting,” (“ASC 280”) in interim periods, and entities with a single reportable segment are required to provide all
the disclosures required by the amendments in ASU 2023-07 and existing segment disclosures in ASC 280. ASU 2023-07 is effective for fiscal
years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption
permitted. The Company adopted ASU 2023-07 as required for the period ended September 30, 2025. The adoption required the Company to provide
additional disclosure, but otherwise it did not materially impact the accompanying unaudited condensed